유유제약2우B

000227KOSPI

56.0 / 100

Reference Date: 2026-06-10

Financial Score25.5 / 40

News Sentiment12.5 / 25

Momentum8.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Revenue metrics are weak. Slightly down 4.4% over the past month, with no recent news.

Score Calculation Basis

Detailed Financial Score

PER

21.14Industry Average 15.003.0Point

Higher than industry avg (caution)

PBR

0.02Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

6.62Industry Average 8.002.5Point

Below industry avg

Debt Ratio

5.50Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20255.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲1.4% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲1551.5% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 3.4% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (17%, downtrend)

Current 10,400Won52-week high 11,67052-week low 10,130

1-month return2.0Point

1m -4.41% (slight drop)

Volume trend5.0Point

Volume increasing

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0